CLINICAL_TRIALS
trial_result
· 2013-01-07
Clinical Trial Update: Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout [Phase 2]
Summary
Phase 2 trial results evaluating a single dose of canakinumab for efficacy and safety in hospitalized patients with acute gout.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Arthritis, Gouty | Phase 2 | Status: COMPLETED | Results posted: 2013-01-07